Co-Prevalence of Quinolone Resistance and Extended-Spectrum Beta-Lactamases among Clinical Enterobacteriaceae Isolates from a Tertiary Hospital in Katsina, Nigeria
DOI:
https://doi.org/10.47430/ujmr.2491.023Keywords:
Antibiotic resistance, Enterobacteriaceae, ESBL, multidrug resistance, Quinolone resistanceAbstract
Study’s Novelty/Excerpt
- This study investigates the co-existence of Extended-Spectrum Beta-Lactamases (ESBLs) and quinolone resistance among clinical Enterobacteriaceae isolates, highlighting the high prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR).
- By employing the VITEK-2 Compact automated identification system, the research demonstrates that a significant proportion of quinolone-resistant Enterobacteriaceae are also ESBL-positive, with co-resistance observed primarily in Escherichia coli and Klebsiella pneumoniae.
- These findings emphasize the critical need for continuous surveillance and antibiotic stewardship to mitigate the growing threat of antimicrobial resistance and align with Sustainable Development Goals (SDG) 3 for good health and well-being.
Full Abstract
Antimicrobial resistance (AMR) poses a major hazard to global public health. It reduces the effectiveness of many antibiotics, making infections harder to cure and raising the likelihood of disease transmission and death. Globally, beta-lactam and quinolone antibiotics are among the commonly prescribed medications. Yet, a multitude of bacteria have evolved distinct multidrug resistance (MDR) characteristics, rendering many of these important drugs worthless. This study aimed to investigate the magnitude of the simultaneous occurrence of Extended-Spectrum Beta-Lactamases (ESBLs) and Quinolone-resistance (co-existence) among clinical Enterobacteriaceae isolates. A total of 95 Enterobacteriaceae pathogens isolated from different human samples were obtained from a Tertiary Hospital in Katsina. Then, the VITEK-2 Compact automated identification system was employed for the identification and antimicrobial susceptibility testing (AST) and the ESBL screening of isolates. This study showed that out of the total 95 isolates, 67 (70.5%) were quinolone-resistant, while 53 (55.8%) were ESBL-positive. Most of the quinolone-resistant (QRE) Enterobacteriaceae were ESBL-positive, 50 (74.6%), and conversely, most of the ESBL-positive Enterobacteriaceae were quinolone-resistant (50, 94.3%). Co-resistance (quinolone-resistance and ESBL-positive) was recorded in 50 (52.63%) of the isolates, all belonging to the Escherichia coli (42, 84.0%) and Klebsiella pneumoniae (8, 16.0%). Almost all the co-resistant isolates were resistant to the tested quinolones [Ciprofloxacin (49, 98.0%) and Levofloxacin (50, 100.0%). The lowest resistance was recorded to Ertapenem
(6.0%), Meropenem (6.0%), and Amikacin (2.0%), and the highest to Ampicillin, Piperacillin and Levofloxacin (100.0% each). Almost all the co-resistant isolates were multidrug-resistant (MDR), 49 (98.0%), while 33 (66.0%) were extensively drug-resistant (XDR). According to the collected samples’ demographic data, the highest prevalences were recorded among males (60.0%, based on gender), adults (50.0%, based on age), and urine (48.0%, based on sample). Continuous surveillance and stewardship are essential to achieve good health and well-being (Sustainable Development Goal 3).
Downloads
References
Abdelrahim, S. S., Hassuna, N. A., Waly, N. G., Kotb, D. N., Abdelhamid, H., & Zaki, S. (2024). Co-existence of plasmid-mediated quinolone resistance (PMQR) and extended-spectrum beta-lactamase (ESBL) genes among clinical Pseudomonas aeruginosa isolates in Egypt. BMC Microbiology, 24(1), 175. https://doi.org/10.1186/s12866-024-03319-z
Ahmed, S. K., Hussein, S., Qurbani, K., Ibrahim, R. H., Fareeq, A., Mahmood, K. A., & Mohamed, M. G. (2024). Antimicrobial resistance: Impacts, challenges, and future prospects. Journal of Medicine, Surgery, and Public Health, 2, 100081. https://doi.org/10.1016/j.glmedi.2024.100081
Egbule, O. S., & Ejechi, B. O. (2021). Prevalence of Extended Spectrum Beta-Lactamases (ESBLs) producing Escherichia coli and Klebsiella pneumoniae among hospitalized patients from Nigeria. Fudma Journal Of Sciences, 5(2), 584 - 595. https://doi.org/10.33003/fjs-2021-0502-676
Éric, K. I., & Papy, H. T. (2024). Beta-Lactam Resistance and Phenotypic Detection of Extended-Spectrum Beta-Lactamase in Enterobacteriaceae Isolated from Community-Acquired Urinary Tract Infections. South Asian Journal of Research in Microbiology, 18(2), 15-24. https://doi.org/10.9734/sajrm/2024/v18i2345
Farajzadeh, S. A., Veisi, H., Shahin, M., Getso, M., & Farahani, A. (2019). Frequency of quinolone resistance genes among extended-spectrum β-lactamase (ESBL)-producing Escherichia coli strains isolated from urinary tract infections. Tropical Medicine and Health, 47(1). https://doi.org/10.1186/s41182-019-0147-8.
Furmanek-Blaszk, B., Sektas, M., & Rybak, B. (2023). High Prevalence of Plasmid-Mediated Quinolone Resistance among ESBL/AmpC-Producing Enterobacterales from Free-Living Birds in Poland. International Journal of Molecular Sciences, 24(16), 12804. https://doi.org/10.3390/ijms241612804
Kariuki, K., Diakhate, M. M., Musembi, S., Tornberg-Belanger, S. N., Rwigi, D., Mutuma, T., ... & Kariuki, S. (2023). Plasmid-mediated quinolone resistance genes detected in Ciprofloxacin non-susceptible Escherichia coli and Klebsiella isolated from Childrenren under five years at hospital discharge, Kenya. BMC Microbiology, 23(1), 129. https://doi.org/10.1186/s12866-023-02849-2
Kimera, Z. I., Mgaya, F. X., Mshana, S. E., Karimuribo, E. D., & Matee, M. I. N. (2021). Occurrence of Extended Spectrum Beta Lactamase (ESBL) Producers, Quinolone and Carbapenem-Resistant Enterobacteriaceae Isolated from Environmental Samples along Msimbazi River Basin Ecosystem in Tanzania. International Journal of Environmental Research and Public Health, 18(16), 8264. https://doi.org/10.3390/ijerph18168264
Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., ...& Monnet, D. L. (2012). Multidrug-resistant, extensively drug-resistant and pandrug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, 18(3), 268-281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
Mujahid, H., Rab’iatu, I. R., Khairiyya, A. K., Mustapha, A., Bishir, I., Ibrahim, D., and Goronyo, J. I. (2023). Biochemical Characterisation and Antimicrobial Susceptibility Profile of Enterobacteriaceae Uropathogens Isolated from Patients with Urinary Tract Infections in Katsina State. Bayero Journal of Pure and Applied Sciences, 14(1): 208 – 213, http://dx.doi.org/10.4314/bajopas.v14i1.33S
Nair, R. R., Andersson, D. I., & Warsi, O. M. (2024). Antibiotic resistance begets more resistance: chromosomal resistance mutations mitigate fitness costs conferred by multi-resistant clinical plasmids. Microbiology Spectrum, 12(5), e04206-23. https://doi.org/10.1128/spectrum.04206-23
Nithyashri, J., & Kulanthaivel, G. (2012). Classification of human age based on Neural Network using FG-NET Aging database and Wavelets. 4th International Conference on Advanced Computing, ICoAC 2012. https://doi.org/10.1109/ICOAC.2012.6416855
Okeke, I. N., de Kraker, M. E., Van Boeckel, T. P., Kumar, C. K., Schmitt, H., Gales, A. C., ... & Laxminarayan, R. (2024). The scope of the antimicrobial resistance challenge. The Lancet, 403(10442), 2426-2438. https://doi.org/10.1016/S0140-6736(24)00876-6
Pakzad, I., Ghafourian, S., Taherikalani, M., Sadeghifard, N., Abtahi, H., Rahbar, M., & Mansory Jamshidi, N. (2011). qnr Prevalence in Extended Spectrum Beta-lactamases (ESBLs) and None-ESBLs Producing Escherichia coli Isolated from Urinary Tract Infections in Central of Iran. Iranian journal of basic medical sciences, 14(5), 458–464. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586849
Shrestha, R. K., Thapa, A., Shrestha, D., Pokhrel, S., Aryal, A., Adhikari, R., ... & Parry, C. M. (2023). Characterization of Transferrable Mechanisms of Quinolone Resistance (TMQR) among Quinolone-resistant Escherichia coli and Klebsiella pneumoniae causing Urinary Tract Infection in Nepalese children. BMC pediatrics, 23(1), 458. https://doi.org/10.1186/s12887-023-04279-5
Tetteh, F. K. M., Ablordey, A., Obeng-Nkrumah, N., and Opintan, J. A. (2024) Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae recovered from patients at the Tamale Teaching Hospital, Ghana. PLoS ONE 19(4): e0300596. https://doi.org/10.1371/journal.pone.0300596
Xiong, Y., Zhang, C., Gao, W., Ma, Y., Zhang, Q., Han, Y., Jiang, S., Zhao, Z., Wang, J., & Chen, Y. (2021). Genetic diversity and co-prevalence of ESBLs and PMQR genes among plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae isolates causing urinary tract infection. The Journal of Antibiotics, 74(6), 397-406. https://doi.org/10.1038/s41429-021-00413-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mujahid Hussaini, Dawud Ibrahim, Ibrahim Bashir, Muhammadu Abdullah Ibrahim, Junaidu Isah Goronyo, Yusuf Mansur
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
